Essex Woodlands Management, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001542339

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltBuy & Hold how tags are computed

Q2 2026 · 5 positions · Total reported value $254.23M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, Essex Woodlands Management, Inc. disclosed 5 equity positions with a combined reported value of $254.23M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were BVS ($122.92M), MDXG ($108.55M), EYPT ($15.51M). By sector, the heaviest allocations are Health Care 93.9%, Industrials 6.1%. Versus the prior quarter, allocation shifted toward Industrials (+0.5pp) and away from Health Care (-0.5pp).

Versus the prior quarter, Essex Woodlands Management, Inc. opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest Essex Woodlands Management, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Essex Woodlands Management, Inc. is an SEC-registered 13F filer based in The Woodlands, TX, United States. As of Q2 2026 it reported 5 US equity positions with a combined value of $254.23M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: THE WOODLANDS, TX, United States
  • SEC registration: 801-73888 (status: Approved), registered 2012-03-20
  • Regulatory AUM (Form ADV): $2.06B as of 2026-05-12
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 19 private funds
  • Website: ewhealthcare.com

Portfolio Structure

  • 5 positions · $254.23M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: BVS (BIOVENTUS INC) at 48.3%
  • Average position size: $50.85M

Sector Tilt

  • Health Care 93.9%
  • Industrials 6.1%
  • (classified holdings cover 100% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund maintained its positions without any additions or changes in the latest quarter, indicating a conservative stance with a focus on holding existing investments. This suggests a lack of significant market sentiment shifts or conviction to alter the portfolio. 2. Key Moves: No additions or reductions were made in the fund's holdings. The portfolio remained static with all positions held at their previous quarter's levels. 3. Portfolio Structure: The portfolio appears to be passive in nature, as there were no active changes to the holdings. It has a strong sector bias towards healthcare, with two healthcare companies representing over 90% of the total value. The risk appetite is moderate, as the holdings are in established sectors without significant additions or shifts indicating a higher risk tolerance. 4. Per-Holding One-Liner: - BVS (BIOVENTUS INC): A biotechnology company focused on developing and commercializing products for metabolic diseases. Business: Developing biotechnology products. - MDXG (MIMEDX GROUP INC): A medical device company focused on ophthalmology. Business: Ophthalmic medical devices. - EYPT (EYEPOINT INC): A biopharmaceutical company focused on therapies for glaucoma. Business: Developing ophthalmic drugs. - TELA (TELA BIO INC COM): A biotechnology company focused on developing therapies for ophthalmic diseases. Business: Ophthalmic therapies. - MNOV (MEDICINOVA INC): A biopharmaceutical company focused on developing therapies for a range of diseases, including oncology. Business: Developing biopharmaceuticals. 5. One-Sentence Style Summary: Essex Woodlands Management, Inc. maintained a stable, passive healthcare-focused portfolio in Q2 2026, with a conservative stance and a preference for established biotech and medical device companies.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 93.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 13.02M $122.92M 48.35%
48.35%
Hold
2 28.20M $108.55M 42.70%
42.70%
Hold
3 1.08M $15.51M 6.10%
6.10%
Hold
4 7.71M $5.79M 2.28%
2.28%
Hold
5 1.11M $1.46M 0.57%
0.57%
Hold

FAQ

What did Essex Woodlands Management, Inc. buy in 2026-Q2?

In its 2026-Q2 13F filing, Essex Woodlands Management, Inc. reported 5 equity positions worth $254.23M in aggregate; its largest disclosed positions were BVS ($122.92M), MDXG ($108.55M), EYPT ($15.51M).

How large is Essex Woodlands Management, Inc.'s portfolio?

Essex Woodlands Management, Inc. reported $254.23M of long equity holdings across 5 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is Essex Woodlands Management, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/essex-woodlands-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →